Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TP
Turning Point Brands, Inc.
TPB
Mkt Cap
$1.26B
Volume
391.18K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TP
TPB
TP
Turning Point Brands, Inc.
TPB
News
·
Altria Premium Drives 85% of Cigarette Profit: Can This Hold?
Mkt Cap
$1.21B
Volume
391.18K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
Altria Premium Drives 85% of Cigarette Profit: Can This Hold?
Altria Group is focusing on its premium cigarette segment, which generates 85% of profitability, as consumers shift toward discount offerings. Marlboro maintained its 59.6% premium segment share but saw overall cigarette market share decline 1.5 points to 39.5%. The company is expanding its discount brand Basic to capture trade-down demand while protecting Marlboro pricing power, with smokeable adjusted OCI rising 2.4% to $3.02 billion.
Zacks Investment Research · Sep 8, 2026
Is Altria's on! PLUS Shaping Up as Its Next Major Growth Engine?
Altria's on! PLUS nicotine pouch product is gaining early momentum with retail presence expanding to approximately 120,000 stores and encouraging repeat purchase rates. However, the company faces intensifying competition from Philip Morris's ZYN and Turning Point Brands's FRE and ALP products, which are also expanding aggressively in the U.S. nicotine pouch market. Altria's stock has underperformed the industry over the past three months, trading at a lower valuation multiple.
Zacks Investment Research · Sep 1, 2026
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision?
Turning Point Brands derives over 40% of its sales from fast-growing nicotine pouches through its Fre and ALP product lines. As the FDA makes regulatory decisions on nicotine pouches and major tobacco companies enter the market, upcoming earnings will reveal whether TPB can maintain its competitive position in this expanding niche.
The Motley Fool · Aug 9, 2026
Altria vs. Turning Point Brands: Which Tobacco Stock Is a Better Buy in 2026?
The article compares two tobacco stocks with contrasting profiles: Altria, a legacy giant generating $9.1B in free cash flow with a 5.82% dividend yield but facing declining smoking rates, and Turning Point Brands, a smaller player experiencing 28% revenue growth driven by nicotine pouches and accessories. Despite Turning Point's higher growth potential, Altria is recommended as the better buy due to its superior dividend yield and lower valuation metrics.
The Motley Fool · Jul 9, 2026
Why Turning Point Brands Stock Fell 15.5% This Week
Turning Point Brands (TPB) stock fell 15.5% this week following reports that the FDA is hesitant to approve new nicotine pouch types due to safety concerns, particularly regarding use among children. The company's fast-growing nicotine pouch brand Fre, which grew 266% year-over-year and represents 34% of revenues, is now facing regulatory headwinds. The stock has declined 50% from its highs.
The Motley Fool · Apr 3, 2026
Why Turning Point Brands Stock Got Smoked Today
Turning Point Brands stock plummeted over 14% after Reuters reported that FDA scientists have significant concerns about nicotine pouches and oral nicotine products, citing risks to new users and children. The regulatory hesitation could delay or block approval of Turning Point's pending products including new Stoker's tobacco lines and its Fre nicotine pouch product line, making growth difficult for the company.
The Motley Fool · Apr 1, 2026
Why Turning Point Brands Stock Collapsed This Week
Turning Point Brands (TPB) stock plummeted 33% this week after missing Q4 earnings expectations and issuing weak 2026 guidance. Despite rapid 266% year-over-year growth in its nicotine pouch business, the company is investing heavily in marketing and distribution, causing adjusted earnings to drop significantly from $119 million annualized to $24-27 million expected in Q1. However, analysts suggest the stock may now be attractively valued at a P/S ratio of 3.7 for a fast-growing company in the nicotine sector.
The Motley Fool · Mar 6, 2026
Better-for-You Stimulant Formats Gain Scale as Consumer Demand Reshapes Delivery Landscape
The oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, driven by consumer shift toward tobacco-free and functional beverage formats. Major players including Celsius Holdings, British American Tobacco, Turning Point Brands, and Keurig Dr Pepper are expanding their portfolios with innovative energy and oral pouch products to capture growing demand for portable, controlled-dose stimulant delivery systems.
Benzinga · Mar 4, 2026
Turning Point Brands Falls As Zig-Zag Sales Decline Offsets Modern Oral Surge
Turning Point Brands (TPB) shares fell over 16.5% on Monday despite beating Q4 2025 earnings expectations with net sales up 29.2% YoY to $121 million. While Modern Oral segment sales surged 266% YoY and the company raised its quarterly dividend, declines in legacy Zig-Zag brand sales weighed on investor sentiment. The company projects FY26 Modern Oral revenue of $180-190 million.
Benzinga · Mar 2, 2026
This High‑Yield Dividend Could Make Patient Investors Rich in Retirement
Altria Group (MO), a Dividend King with 56 consecutive years of dividend growth, offers a 6.3% forward dividend yield and has delivered 18% annualized returns over five years, outperforming the S&P 500. However, the company lags in smoke-free product innovation compared to competitor Philip Morris International, with 88% of revenue still from smokeable products. Despite past failures in smoke-free ventures, modest success in future smokeless products could significantly boost valuations, making it an attractive buy-and-hold opportunity for dividend investors.
The Motley Fool · Feb 18, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
TP
TPB
Turning Point Brands, Inc.
Buy
Sell
Market
Limit
Soon
TPB
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any TPB yet.
Related Tickers
Earnings
Dividends
Last · Sep 18
Quarterly
Amount
$0.0800
Yield
0.50%
Annual
$0.32